New biomarker predicts liver cancer recurrence and immunotherapy response
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Disease Area, Immunotherapy, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Research, Tumours, xOncofetal EcosystemAnalysis of the environment that surrounds liver cancer tumours has revealed that patients with a high concentration of a certain cell type have early return of aggressive cancer but do…
Federal government supports new treatment to clear blocked arteries
By Richard Schoonraad | Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Diabetes, Funding, News & Events, ResearchA Western Australian medical research team developing a new treatment for cardiovascular disease has received $2,147,254 in Federal government funding to develop a first-ever drug to clear blocked arteries. The…
WA researchers excel in nationally competitive grants
By Richard Schoonraad | Breast Cancer, Breast Cancer, Cancer, Cancer, Cancer Epigenetics, Cardiovascular Disease, Cardiovascular Disease, Epigenetics and Genomics Laboratory, Funding, Genome Biology and Genetic Diseases, Media Releases, Mitochondrial disease, Mitochondrial Disease, Mitochondrial Medicine and Biology, News & Events, Research, TranslationEight (8) Federal government grants awarded to the Harry Perkins Institute of Medical Research Two of Australia’s most significant research grants, given only to the nation’s highest performing researchers, have…
Australian Cancer Plan consultation period open
By Richard Schoonraad | Cancer, Cancer, Cancer Centre News, News & EventsFurther to the Federal Government commitment of $375M to establish the Perkins-led WA Comprehensive Cancer Centre, the Government has been consulting with stakeholders to develop the Australian Cancer Plan. This…
$3.5 million research collaborative brings cell therapy for solid cancers to WA
By Richard Schoonraad | Cancer, Cancer, Funding, Melanoma, Melanoma Discovery, Melonoma, News & Events, Personalised Medicine, ResearchResearchers from the Western Australia Melanoma Initiative (WAMI), a cancer research collaborative, will implement a specialised immune cell therapy for cancer patients in WA, thanks to a $2.5 million grant…
Perkins welcomes release of Australian Cancer Plan
By Richard Schoonraad | Cancer, Cancer, Cancer Centre News, News & EventsStatement from Professor Peter Leedman AO, Director, Harry Perkins Institute of Medical Research, on the release of the Australian Cancer Plan: The Harry Perkins Institute of Medical Research (the Perkins)…
WA scientists win Hearts and Minds
By Richard Schoonraad | Development of Improved Diagnostics for Genetic Disease, Development of Therapies for Selected Genetic Muscle Diseases, Disease Area, Funding, Genes, Genetic Disease, Genetic Disease, Genetic Neuromuscular Disorders, Genetics, Media Releases, Muscles, Muscular Dystrophy, Neurological Disorders, News & Events, Rare Disease Genetics and Functional GenomicsFirst West Australian team to attract unique listed investment company funds One of Australia's Top 30 Corporate Philanthropists, Hearts and Minds Investments Limited (ASX: HM1) has made its first donation…
Hope for new drug to fight liver cancer
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Liver, Liver Cancer, Liver Cancer, Liver Disease, News & EventsPrimary liver cancer is a deadly illness and one of the fastest growing cancer types in the world. Now researchers from the Harry Perkins Institute of Medical Research have developed…